A colleague of mine spent fifteen years as a healthcare sales representative. When I asked him to describe how the role had changed since he started, he said: "I used to be the golf caddy. Now I'm the drinks carrier."
That is a fairly brutal description of what has happened to field force effectiveness across healthcare over the last decade. The caddy is inside the game. They know the course, they shape the shot, they are irreplaceable. The drinks carrier is useful. They are not integral.
This piece is drawn from a White Paper Chat I recorded with Badri Wadu-Utegi, a commercial strategy practitioner who has spent the last several years working at the intersection of digital transformation and healthcare sales. What follows is not a transcript. It is the argument we built together, compressed and sharpened.
The access problem is not the real problem
Most healthcare commercial leaders are aware that HCP access has declined. The figure we opened with on the recording was 58 per cent. That is the working number for how far access has fallen across key markets. Most sales teams and their managers know it is harder to get in front of clinicians than it was ten years ago.
What fewer have absorbed is what it means for the structure of their commercial model.
If your model was designed when access was high and the rep created demand in the room, and you now operate in a world where access is 40 per cent of what it was, you have not just got a headcount problem. You have a model problem. The reflex response, which is to hire more reps to compensate for lower conversion rates, has the effect of accelerating the constraint. The more companies flood a shrinking access window, the pickier clinicians become about which conversations they take.
The companies generating consistent commercial results are not trying to hire their way through this. They are rethinking what the rep is actually for.
From pilot to air traffic controller
Badri used a phrase I thought was sharp: the sales rep has shifted from being the pilot to being the air traffic controller. The pilot is in one plane. The air traffic controller is managing multiple conversations across multiple stakeholders simultaneously, none of which they can control directly.
The modern healthcare sale is rarely a single-rep, single-clinician exchange. There is a Value Assessment Committee. There is procurement. There is the clinical champion who has to persuade their peers. The rep's role is not to close a deal in the room. It is to keep the right conversations moving in the right direction across a stakeholder map the rep may never see in full.
This requires a fundamentally different skill set than the one most healthcare companies train for. The field training most reps receive is built for the golf caddy model: know the product, know the objections, manage the call. Very little of it prepares a rep for operating as an air traffic controller in a multi-stakeholder procurement process with an eighteen-month sales cycle.
The data bloat problem
One of the most useful parts of the conversation was Badri's diagnosis of what has gone wrong with CRM adoption in healthcare field forces.
The pattern he described is recognisable to anyone who has managed a commercial team. A question arises. Someone builds a dropdown form to capture data on it. Another question arises. Another form is added. The forms accumulate. Before long, the rep is spending a material portion of every call not selling but filling in administrative returns that will be mined by a team at headquarters who are themselves struggling to translate data into insight.
Reps hate this. Not because they are lazy, but because they can see that nothing changes as a result of it. The data goes in. No action comes out. The next quarter, the same forms are there, plus some new ones.
Badri's prescription was lean iteration: collect only the data that feeds directly back into how the rep goes into the next conversation. If the data you are collecting is not changing the playbook, it is probably data bloat.
What the playbook actually is
We spent a significant portion of the recording on what a commercial playbook is and what it is not.
The version that most companies produce is essentially a product manual with some objection handling appended. It is a static document that describes how the company believes the product should be sold, written at launch and updated infrequently. New reps are handed it. Most read the first third. A few never open it.
The more useful version is something different. It captures what the best performing reps actually do: the objection handling that works in the field, the framing that lands, the pathway through a complex account that has been walked successfully. It is peer-to-peer knowledge, systematised.
Badri made the point that reps will contribute to a playbook if they believe it will change how they operate tomorrow. If it becomes a dead archive, they stop contributing. The data-feedback problem and the playbook problem are connected.
What the technology is beginning to enable is a version of the playbook that meets the rep before the call rather than sitting on a shelf in the office. A profile of the clinician they are about to see. Recent publications, known objections to this therapy class, the last three interactions this account has had with the company. Badri called it the transformation of in-car prep: the time reps traditionally spent in hospital car parks mentally rehearsing the call before walking in. That preparation, done well, is the difference between a good conversation and a painful one.
Three tools, not thirteen
One of the clearest arguments in the recording was about tool proliferation. Large pharmaceutical companies in particular have a tendency to accumulate tools: different CRMs in different markets, engagement platforms, reporting systems, medical information portals. In one case Badri described, a single multinational field force was operating across thirteen different CRM implementations.
The reps at the sophisticated end had a hundred in-house developers maintaining their system. The reps at the other end were managing interactions on what was functionally a spreadsheet.
The practical argument we landed on was that a field force needs three things clearly, not thirteen things poorly. Instruction: what is the rep supposed to do, in this conversation, with this clinician, given what we know about this account. Engagement: the tools that enable the rep to demonstrate value in the room, two clicks away, not buried in a folder. Reporting: a mechanism to feed what happened back into the playbook, fast enough that the rep can see it acted upon.
When those three work together, the rep does not feel like an administrative function. They feel like the intelligence node they are.
The measurement question
The conversation ended on a question that I think is the most important one in healthcare commercial strategy right now: how do you justify investment in tooling and process against the reflex of simply hiring more reps?
The standard argument made by decision-makers is a straightforward arithmetic: divide current revenue by current rep headcount, multiply by the proposed number of new reps, project the return. The argument for digital investment does not reduce to that calculation cleanly, which means it loses by default.
Badri's challenge to this was structural. A sales force armed only with headcount and without the tools, information, and marketing behind them is, to use his phrase, a large army armed with sticks and stones. The question is not how big the army is. It is how effective each unit is, given what it has to work with.
Category leaders in healthcare do not just have larger field forces than their competitors. They have better playbooks, better pre-call preparation, and better feedback loops between the field and headquarters. The headcount is the final multiplier on a system that already works. Without the system, more headcount produces diminishing returns faster than most commercial directors are prepared to admit.
Badri and I published a white paper alongside this conversation on the modernisation of the healthcare commercial process. The recording is available on Spotify and Apple Podcasts. If you want to talk through what this means for your field force structure, book a triage call.
What next?